Radiation dose and subsequent risk for stomach cancer in long-term survivors of cervical cancer
- PMID: 23707149
- PMCID: PMC3831516
- DOI: 10.1016/j.ijrobp.2013.04.010
Radiation dose and subsequent risk for stomach cancer in long-term survivors of cervical cancer
Abstract
Purpose: To assess the dose-response relationship for stomach cancer after radiation therapy for cervical cancer.
Methods and materials: We conducted a nested, matched case-control study of 201 cases and 378 controls among 53,547 5-year survivors of cervical cancer diagnosed from 1943 to 1995, from 5 international, population-based cancer registries. We estimated individual radiation doses to the site of the stomach cancer for all cases and to corresponding sites for the matched controls (overall mean stomach tumor dose, 2.56 Gy, range 0.03-46.1 and after parallel opposed pelvic fields, 1.63 Gy, range 0.12-6.3).
Results: More than 90% of women received radiation therapy, mostly with external beam therapy in combination with brachytherapy. Stomach cancer risk was nonsignificantly increased (odds ratio 1.27-2.28) for women receiving between 0.5 and 4.9 Gy to the stomach cancer site and significantly increased at doses ≥ 5 Gy (odds ratio 4.20, 95% confidence interval 1.41-13.4, Ptrend=.047) compared with nonirradiated women. A highly significant radiation dose-response relationship was evident when analyses were restricted to the 131 cases (251 controls) whose stomach cancer was located in the middle and lower portions of the stomach (Ptrend=.003), whereas there was no indication of increasing risk with increasing dose for 30 cases (57 controls) whose cancer was located in the upper stomach (Ptrend=.23).
Conclusions: Our findings show for the first time a significant linear dose-response relationship for risk of stomach cancer in long-term survivors of cervical cancer.
Published by Elsevier Inc.
Conflict of interest statement
Conflicts of Interest Notifications
There are no conflicts of interest to report.
Figures
References
-
- Arbyn M, Castellsague X, de Sanjose S, et al. Worldwide burden of cervical cancer in 2008. Ann Oncology. 2011;22:2675–2686. - PubMed
-
- Howlader N, Noone AM, Krapcho M, et al., editors. SEER Cancer Statistics Review, 1975–2010. National Cancer Institute; Bethesda, MD: 2012.
-
- Kleinerman RA, Boice JD, Jr, Storm HH, et al. Second primary cancer after treatment for cervical cancer. An international cancer registries study. Cancer. 1995;76:442–452. - PubMed
-
- New malignancies following cancer of the cervix uteri, vagina, and vulva. In: Kleinerman RA, Kosary CL, Hildesheim A, editors; Curtis RE, Freedman DM, Ron E, et al., editors. New malignancies among cancer survivors: SEER cancer registries. 1973-2000. Bethesda: National Institutes of Health; 2006.
-
- Chaturvedi AK, Engels EA, Gilbert ES, et al. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst. 2007;99:1634–1643. - PubMed
Publication types
MeSH terms
Grants and funding
- N02 CP031136/CP/NCI NIH HHS/United States
- N01-CP-31157/CP/NCI NIH HHS/United States
- N01 CP031019/CP/NCI NIH HHS/United States
- N02 CP055503/CP/NCI NIH HHS/United States
- N01-CP-31156/CP/NCI NIH HHS/United States
- N01 CP031154/CP/NCI NIH HHS/United States
- Y99 CA999999/CA/NCI NIH HHS/United States
- N01-CP-31155/CP/NCI NIH HHS/United States
- N02 CP031003/CP/NCI NIH HHS/United States
- Z99 CA999999/ImNIH/Intramural NIH HHS/United States
- N01 CP031156/AI/NIAID NIH HHS/United States
- N01-CP-31003/CP/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
